BIONEXUS GENE LAB CORP (BGLC)

US0906282076 - Common Stock

0.361  -0.1 (-21.64%)

Premarket: 0.3321 -0.03 (-8.01%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
13.36M
17.30%
10.93M
-18.19%
9.771M
-10.61%
EBITDA
YoY % growth
1.14M
-16.18%
-200K
-117.54%
-2.51M
-1,155.17%
EBIT
YoY % growth
1.05M
-17.32%
-290K
-127.62%
-2.594M
-794.34%
Operating Margin
7.86%-2.65%-26.54%
EPS
YoY % growth
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.63M
3.00%
%
Q2 2024
Q2Q % growth
1.975M
-23.17%
%
Q1 2024
Q2Q % growth
2.382M
0.08%
%
Q4 2023
Q2Q % growth
2.273M
-19.96%
%
Q3 2023
Q2Q % growth
2.554M
-1.02%
%
Q2 2023
Q2Q % growth
2.57M
3.21%
%
Q1 2023
Q2Q % growth
2.38M
-21.45%
%
Q4 2022
Q2Q % growth
2.84M
-12.62%
%
Q3 2022
Q2Q % growth
2.58M
-27.93%
%
Q2 2022
Q2Q % growth
2.49M
-19.42%
%
Q1 2022
Q2Q % growth
3.03M
-12.17%
%
Q4 2021
Q2Q % growth
3.25M
-71.39%
%
Q3 2021
Q2Q % growth
3.58M
15.86%
%
Q2 2021
Q2Q % growth
3.09M
180.91%
%
Q1 2021
Q2Q % growth
3.45M
12.38%
%
Q4 2020
Q2Q % growth
11.36M
22,620.00%
%
Q3 2020
Q2Q % growth
3.09M
15,350.00%
%
Q2 2020
Q2Q % growth
1.1M
5,400.00%
%
Q1 2020
Q2Q % growth
3.07M
10,133.33%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A